Epstein Secrets

he strategic management and ongoing development of the legal entities. fi This introduced the principle of differentiated management. Consequently, the Nutrition & Care and Resource Efficiency segments now have an even stronger focus on growth, while the Performance Materials segment is run as a financing business.

2015 EVONIK INDUSTRIES At its meeting in December, the Supervisory Board discussed the Declaration of Conformity in compliance with Section 161 of the German Stock Corporation Act (AktG), the budget for 2016, the mid-term planning for the period to 2018, and progress in implementing the measures adopted following the efficien

ew applications and enter new markets. In principle, these opportunities and risks may affect all segments, but they are particularly relevant for the Nutrition & Care and Per- formance Materials segments. One potential risk factor for our amino acids business, for example in Asia, is the possible impact of substa

Section 315 Paragraph 4 of the German Com- mercial Code (HGB) and explanatory report by the Executive Board pursuant to Section 176 Paragraph 1 of the German Stock Corporation Act (AktG) Structure of issued capital The capital stock of Evonik Industries AG is €466,000,000 and is divided into 466,000,000 no-par registered sha

e Board a) NATIONAL-BANK AG b) Borussia Dortmund Geschaftsfahrungs-GmbH Dr. Ralph Sven Kaufmann, Dusseldorf (since July 1, 2015) Responsible for the Nutrition & Care, Resource Efficiency and Performance Materials segments a) Evonik Nutrition & Care GmbH (since July 1, Juli 2015*, Chair since September 14, 2015)

boards. b) Membership of comparable German and foreign supervisory bodies of business enterprises pursuant to Section 125 Paragraph 1 Sentence 5 of the German Stock Corporation Act (AMC). EFTA00598848 216 FINANCIAL REPORT 2015 EVONIK INDUSTRIES Executive Board of Evonik Industries AG Dr. Klaus Engel, Mulheirn an der Ruhr